Literature DB >> 16871925

Intranasal deposition of nebulized saline: a radionuclide distribution study.

Peter H Hwang1, Rachel J Woo, Karen J Fong.   

Abstract

BACKGROUND: Despite the popularity of various nasal sprays and nebulizers, there are limited data regarding the anatomic distribution of particles generated by these devices. This pilot study sought to characterize distribution patterns of nebulized and sprayed saline particles in normal subjects and postsurgical sinus patients.
METHODS: Fifteen subjects were studied in three trials: metered-dose nasal spray bottle versus vortex-propelled nebulizer in normal subjects, passive-diffusion nebulizer versus vortex nebulizer in normal subjects, and passive nebulizer versus vortex nebulizer in postsurgical sinus patients. Radiolabeled saline was administered, and nose, lungs, and stomach were imaged. Images were scored by four blinded reviewers for degree of penetration at nine anatomic subsites.
RESULTS: Compared with spray bottle, the vortex nebulizer showed more focal intranasal distribution with reduced nasopharyngeal, pharyngeal, and gastric penetration in normal subjects. Three of five subjects showed probable frontal sinus penetration by vortex nebulizer, but no other sinus penetration was noted. No patients showed sinus penetration with the spray bottle. In a separate trial against the passive nebulizer, the vortex nebulizer again showed a greater tendency for sinus penetration in normal subjects, with three of five showing some degree of sphenoid penetration and one of five showing slight maxillary penetration. In contrast, no sinus penetration was observed with the passive nebulizer. In the postsurgical patient cohort, minimal sinus penetration was noted with either the vortex nebulizer or the passive nebulizer. Despite surgically patent sinuses, only one of five subjects showed any type of sinus penetration.
CONCLUSION: The nebulizer and nasal spray devices tested in general showed limited penetration of the sinuses in both normal and postoperative patients. The device showing greatest promise for sinus penetration in normal patients was the vortex nebulizer, with an overall penetration rate in normal patients of 30% in the frontal, 30% in the sphenoid, and 10% in the maxillary. Understanding delivery patterns of topical therapies may be important in evaluating the efficacy of various topical treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871925     DOI: 10.2500/ajr.2006.20.2861

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  7 in total

1.  Topical contrast agents to improve soft-tissue contrast in the upper airway using cone beam CT: a pilot study.

Authors:  N A Alsufyani; M L Noga; W H Finlay; P W Major
Journal:  Dentomaxillofac Radiol       Date:  2013-04-26       Impact factor: 2.419

2.  Efficacy and safety of delivery of topical medication on to the frontal sinus at different head positions after frontal sinusotomy.

Authors:  Yu-Xiao Wu; Min Wang; Hui Li; Zhi-Min Xing; Mu-Han Shi; Shi-En Huang; Yan Liu; Cong-Li Geng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-13       Impact factor: 2.503

Review 3.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

4.  Topical Drug Delivery for Chronic Rhinosinusitis.

Authors:  Jonathan Liang; Andrew P Lane
Journal:  Curr Otorhinolaryngol Rep       Date:  2012-12-27

Review 5.  Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.

Authors:  Sylvia Natalie Kłodzińska; Petra Alexandra Priemel; Thomas Rades; Hanne Mørck Nielsen
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

6.  A computational study of functional endoscopic sinus surgery and maxillary sinus drug delivery.

Authors:  M R Wofford; J S Kimbell; D O Frank-Ito; V Dhandha; K A McKinney; G M Fleischman; C S Ebert; A M Zanation; B A Senior
Journal:  Rhinology       Date:  2015-03       Impact factor: 3.681

Review 7.  Novel drug-delivery systems for patients with chronic rhinosinusitis.

Authors:  Silviu Albu
Journal:  Drug Des Devel Ther       Date:  2012-05-31       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.